CIRT will examine if taking low-dose methotrextate (LDM) once a week will reduce inflammation and decrease the risk for heart attacks, strokes, and death among men and women who have had a heart attack or have major blockages in more than one coronary artery.
https://clinicaltrials.gov/ct2/show/NCT02576067?term=CIRT&rank=2